esteban, r., Cantero Hernández, H., Casado, M. A., & Domínguez-Hernández, R. (2024). Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years.
Citación estilo Chicagoesteban, rafael, Helena Cantero Hernández, Miguel Angel Casado, y Raquel Domínguez-Hernández. Evaluation of the Clinical and Economic Value of Sofosbuvir/velpatasvir (SOF/VEL) in Patients With Chronic Hepatitis C in Spain During the Last 5 Years. 2024.
Cita MLAesteban, rafael, Helena Cantero Hernández, Miguel Angel Casado, y Raquel Domínguez-Hernández. Evaluation of the Clinical and Economic Value of Sofosbuvir/velpatasvir (SOF/VEL) in Patients With Chronic Hepatitis C in Spain During the Last 5 Years. 2024.